Back to BCRX
BlackRock Finance, Inc. → BCRX
BlackRock Finance, Inc. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
45
Latest value
$1.2M
Q2 2024
Peak value
$57.5M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $3.2M |
| Q4 2023 | $4K |
| Q4 2023 | $62K |
| Q4 2023 | $3M |
| Q4 2023 | $6.2M |
| Q4 2023 | $54.8M |
| Q4 2023 | $39.5M |
| Q4 2023 | $199K |
| Q4 2023 | $238K |
| Q4 2023 | $466K |
| Q4 2023 | $19K |
| Q4 2023 | $3.4M |
| Q4 2023 | $207K |
| Q4 2023 | $201K |
| Q4 2023 | $440K |
| Q1 2024 | $2.4M |
| Q1 2024 | $4K |
| Q1 2024 | $52K |
| Q1 2024 | $2.5M |
| Q1 2024 | $5.2M |
| Q1 2024 | $44.7M |
| Q1 2024 | $34.2M |
| Q1 2024 | $168K |
| Q1 2024 | $202K |
| Q1 2024 | $395K |
| Q1 2024 | $16K |
| Q1 2024 | $3M |
| Q1 2024 | $187K |
| Q1 2024 | $171K |
| Q1 2024 | $568K |
| Q2 2024 | $3.5M |
| Q2 2024 | $4K |
| Q2 2024 | $60K |
| Q2 2024 | $3.4M |
| Q2 2024 | $8M |
| Q2 2024 | $57.5M |
| Q2 2024 | $44.6M |
| Q2 2024 | $210K |
| Q2 2024 | $245K |
| Q2 2024 | $496K |
| Q2 2024 | $20K |
| Q2 2024 | $3.3M |
| Q2 2024 | $636K |
| Q2 2024 | $207K |
| Q2 2024 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2024 | $1.2M | 190.9K | — | — |
| Q2 2024 | $207K | 33.6K | — | — |
| Q2 2024 | $636K | 102.8K | — | — |
| Q2 2024 | $3.3M | 541.5K | — | — |
| Q2 2024 | $20K | 3.2K | — | — |
| Q2 2024 | $496K | 80.3K | — | — |
| Q2 2024 | $245K | 39.7K | — | — |
| Q2 2024 | $210K | 34.0K | — | — |
| Q2 2024 | $44.6M | 7.22M | — | — |
| Q2 2024 | $57.5M | 9.30M | — | — |
| Q2 2024 | $8M | 1.29M | — | — |
| Q2 2024 | $3.4M | 547.3K | — | — |
| Q2 2024 | $60K | 9.7K | — | — |
| Q2 2024 | $4K | 697 | — | — |
| Q2 2024 | $3.5M | 566.1K | — | — |
| Q1 2024 | $568K | 111.9K | — | — |
| Q1 2024 | $171K | 33.6K | — | — |
| Q1 2024 | $187K | 36.8K | — | — |
| Q1 2024 | $3M | 597.2K | — | — |
| Q1 2024 | $16K | 3.2K | — | — |
| Q1 2024 | $395K | 77.7K | — | — |
| Q1 2024 | $202K | 39.7K | — | — |
| Q1 2024 | $168K | 33.2K | — | — |
| Q1 2024 | $34.2M | 6.72M | — | — |
| Q1 2024 | $44.7M | 8.80M | — | — |
| Q1 2024 | $5.2M | 1.01M | — | — |
| Q1 2024 | $2.5M | 486.4K | — | — |
| Q1 2024 | $52K | 10.3K | — | — |
| Q1 2024 | $4K | 697 | — | — |
| Q1 2024 | $2.4M | 474.6K | — | — |
| Q4 2023 | $440K | 73.5K | — | — |
| Q4 2023 | $201K | 33.6K | — | — |
| Q4 2023 | $207K | 34.6K | — | — |
| Q4 2023 | $3.4M | 567.9K | — | — |
| Q4 2023 | $19K | 3.2K | — | — |
| Q4 2023 | $466K | 77.7K | — | — |
| Q4 2023 | $238K | 39.7K | — | — |
| Q4 2023 | $199K | 33.2K | — | — |
| Q4 2023 | $39.5M | 6.60M | — | — |
| Q4 2023 | $54.8M | 9.15M | — | — |
| Q4 2023 | $6.2M | 1.03M | — | — |
| Q4 2023 | $3M | 497.0K | — | — |
| Q4 2023 | $62K | 10.3K | — | — |
| Q4 2023 | $4K | 697 | — | — |
| Q4 2023 | $3.2M | 529.6K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M